Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Association Between Pertuzumab-Associated Diarrhoea and Rash and Survival Outcomes in Patients With HER2-Positive Metastatic Breast Cancer: Exploratory Analysis From the CLEOPATRA TrialEur. J. Cancer 2021 Feb 01;144(xx)351-359, A R Ferreira, S Ferreira, M Lambertini, C Maurer, S Martel, L Costa, N Ponde, E de Azambuja
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.